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Abstract
Eotaxin is an important inflammatory chemokine in eosinophil chemotaxis and activation and, thus, is implicated in asthma. Recently, obesity 
was associated with an increased prevalence of asthma, but the relationship between obesity and eotaxin expression has only been partially understood
in obese mice and human studies. Therefore, we studied the expression patterns of eotaxin in 3T3-L1 preadipocytes/adipocytes to determine whether
eotaxin levels are influenced by body weight gain and/or reduction in diet-induced obese mice. First, we investigated eotaxin expression during 
differentiation in 3T3-L1 adipocytes. Then, we treated 3T3-L1 preadipocytes/adipocytes with tumor necrosis factor-alpha (TNF-α), eotaxin, interleukin
(IL)-4, IL-5, or leptin. To examine the effects of weight loss in high-fat diet induced obese mice, we fed C57BL/6 mice a high-fat diet or a normal
diet for 26 weeks. Then, half of the high-fat diet group were fed a normal diet until 30 weeks to reduce weight. Epididymal adipose tissue, visceral
adipose tissue, serum, and bronchoalveolar fluid of mice were examined for eotaxin expression. The results showed that eotaxin expression levels
increased with adipocyte differentiation and that more eotaxin was expressed when the cells were stimulated with TNF-α, eotaxin, IL-4, IL-5, or 
leptin. An in vivo study showed that eotaxin levels were reduced in visceral adipose tissues when high-fat diet fed mice underwent weight loss. 
Taken together, these results indicate a close relationship between eotaxin expression and obesity as well as weight loss, thus, they indirectly show
a relation to asthma. 
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Introduction2)
Eotaxin (CCL11), an inflammatory chemokine, is an eosinophil- 
specific chemoattractant that induces infiltration of eosinophils 
to the lung. Moreover, it is the predominant substance in 
eosinophilia [1,2]. Human eotaxin is a non-glycosylated polypeptide 
comprised of 74-amino-acid residues with a molecular weight 
of 8.3-kDa [3]. Eotaxin is secreted by epithelial cells, fibroblasts, 
macrophages, and eosinophils [4-6]. 
In human studies, obese individuals have higher amounts of 
adipose tissue and serum eotaxin levels than lean individuals. 
In particular, visceral fat secretes more eotaxin than subcutaneous 
adipose tissue [7]. In 2006, a study of the correlation between 
weight and serum eotaxin levels showed that of 79 types of 
proteins, including growth factors, cytokines, and chemokines, 
the levels of monocyte chemoattractant protein-4 and eotaxin 
were higher in obese individuals than lean individuals, according 
to an assessment of serum in eight lean individuals and seven 
obese individuals with antibody-based protein microarray [8]. 
This result shows that eotaxin and obesity have a close relationship 
in humans. 
Many clinical studies have reported that obesity is associated 
with the incidence and severity of asthma [9-11], and that 
increases in body mass index (BMI) affect asthma symptoms, 
airway hyper-responsiveness, and atopy [12,13]. However, clear 
correlations have not been established. 
A relationship between obesity and asthma was clearly shown 
when obese patients with asthma showed reduced symptoms of 
asthma and reduced serum eotaxin levels during weight loss 
attempts [14,15]. However, this only revealed the phenomenon, 
and more research on the mechanism is needed. 
In human adipocytes (SGBS), assessed by DNA microarray, 
the eotaxin gene was expressed and its level increased with tumor 
necrosis factor-alpha (TNF-α) treatment [16]. However, according 
to the research released by other groups in 2007, eotaxin mRNA 
expression in 3T3-L1 preadipocytes is more than that of 
differentiated adipocytes, and increases with lipopolysaccharide 
(LPS) stimulation [17]. Moreover, stroma vascular cells, including 
macrophages, preadipocytes, and eosinophils that infiltrated 
adipose tissue, secrete more eotaxin than adipocytes in adipose 
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tissue [7]. These results show the necessity for in-depth research 
on eotaxin secretion in differentiated adipocytes and eotaxin 
secretion in adipocytes due to interaction with infiltrates. 
A study modeled on diet-induced obese mice showed that 
although obese mice had higher eotaxin levels in bronchoalveolar 
lavage fluid (BALF), serum eotaxin levels were similar to the 
control [18]. Conversely, other studies have shown that obese 
mice have 2-fold higher serum eotaxin levels than controls [7]. 
These contradictory results on eotaxin levels in serum and BALF, 
again, mandate research on the change in eotaxin level due to 
obesity. In this study, we examined eotaxin expression in 3T3-L1 
adipocytes and examined the effects of obesity and weight loss 
by investigating the change in eotaxin levels in BALF, serum, 
and adipose tissues of mice.
Materials and Methods
Materials
High-glucose DMEM, bovine calf serum (BCS), and fetal 
bovine serum (FBS) were purchased from Hyclone (Logan, Utah, 
USA). Trypsin/EDTA, insulin, dexamethasone (dex), 3-isobutyl- 
1-methylxanthine (IBM-X) were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). 
Trizol for RNA extraction and ImProm II reverse transcriptase 
were purchased from Promega (Madison, WI, USA). 2 × SYBR 
green mix was purchased from USB (Cleveland, OH, USA). All 
primers and oligo dT primers were purchased from Bioneer 
(Daejeon, Korea). 
Mouse eotaxin ELISA kits were purchased from R & D 
Systems (Minneapolis, MN, USA). Recombinant mouse TNF-α 
was purchased from Sigma-Aldrich. Recombinant mouse eotaxin, 
IL-4, IL-5, and leptin were purchased from PromoKine (Heidelberg, 
Germany). 
3T3-L1 adipocytes culture and sample treatment 
Mouse 3T3-L1 pre-adipocytes were grown to confluence in 
DMEM with 10% BCS at 37℃ in a humidified atmosphere of 
5% CO2. At 1 day post-confluence (designated day 0), cell 
differentiation was induced with a mixture of IBMX (0.5 mM), 
dex (0.25 mM), and insulin (1 mg/ml) in DMEM containing 10% 
FBS. On day 2 and thereafter, DMEM containing 10% FBS and 
insulin (1 mg/ml) only was subsequently replaced every 2 days.
3T3-L1 preadipocytes or 8-day post-differentiation adipocytes 
were treated with 10 ng/ml TNF-α, eotaxin, IL-4, IL-5, or 100 
pg/ml leptin for 30 min, 1, 2, 4, 8, 12, and 24 hrs, depending 
on the experimental procedures. 
Mice
Four-week-old lean C57BL/6 mice were purchased from 
Hyochang Science (Daegu, Korea). The mice were fed a standard 
chow or high-fat (40% beef tallow) diet until the age of 26-weeks, 
then half of the high-fat group was converted to feed on the 
chow diet until 30 weeks. All mice were housed in cages on 
a 12-h day, 12-h night cycle, temperature, 22 ± 1℃; humidity, 
55 ± 5%. 
Mice were killed under ether anesthesia. Blood was collected 
in EDTA-coated tubes, and serum was separated by centrifuga-
tion (500 × g, 4℃, 10 min). Epididymal and visceral adipose 
tissue were collected by dissection, weighed, quickly frozen by 
immediate immersion in liquid nitrogen, and stored at -70℃ for 
RNA isolation. The lungs were washed by flushing with 
phosphate-buffered saline (PBS) through the tracheal cannula. 
The BAL fluid was centrifuged (500 × g for 10 min at 4℃), 
and the supernatant was stored at -20℃.
RNA extraction and cDNA synthesis
Total RNA was isolated from 3T3-L1 adipocytes using Trizol 
reagent. First-strand cDNA synthesis was performed with 1 mg 
of total RNA using Improm II reverse transcriptase (Promega).
Real-time RT-PCR
Real-time RT-PCR analysis was performed using an Applied 
Biosystems 7500 Real Time PCR system (Applied Biosystems, 
Foster City, CA, USA). Samples (mixture of 2 × SYBR Green 
Mix, 0.2 μM of the appropriate primers, and cDNA) were 
incubated in the Applied Biosystems 7500 Real Time PCR 
system for an initial denaturation at 95℃ for 2 min, followed 
by 40 PCR cycles. Each cycle consisted of 95℃ for 15 s and 
60℃ for 1 minute. Melting curve profiles (cooling the sample to 
60℃ for 1 minute and heating slowly to 95℃ while continuously 
measuring fluorescence) were produced at the end of each PCR 
to confirm amplification of specific transcripts. The oligonucleotide 
primers for the experiments were: beta-actin forward; 5'-AGC 
CAT GTA CGT AGC CAT CC-3' and reverse; 5'-TCC CTC 
TCA GCT GTG GTG GTG AA-3', eotaxin forward; 5'-GAA 
TCA CCA ACA ACA GAT GCA C-3' and reverse; 5'-ATC CTG 
GAC CCA CTT CTT CTT-3'. 
Measurement of eotaxin by ELISA
We measured serum, BALF, and cell supernatant eotaxin levels 
with a mouse eotaxin immunoassay kit (R & D Systems), 
according to the manufacturer’s protocol. 
Statistical analysis
The data were analyzed by Student’s t-test at the P< 0.05 level. Hyun-Jung Kim et al. 13
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Fig. 1. Changes in eotaxin expression during 3T3-L1 adipocyte differentiation.
(a) 3T3-L1 adipocytes were collected every other day during differentiation, and the
relative amount of eotaxin mRNA was detected using real-time RT-PCR. (b) 3T3-L1 
adipocyte  supernatants  were  collected  every  other  day  during  differentiation,  and 
the  eotaxin  secretion  level  was  detected  with  an  ELISA  kit  (D0:  preadipocytes; 
D2-D10:  2-10  days  after  inducing  differentiation;  * P < 0.05,  ** P < 0.01,  *** P <
0.001).
(a)
(b)
Fig. 2. Change in eotaxin expression in 3T3-L1 preadipocytes due to 
differentiation components. Preadipocytes  were  treated  with  several  different 
differentiation  media  for  24  hours.  (a)  The  relative  amount  of  eotaxin  mRNA  was 
determined by real-time RT-PCR, and (b) eotaxin secretion was detected with an 
ELISA kit (fetal bovine serum [FBS]: DMEM + 10% FBS, FBS + insulin [Ins]: DMEM 
+1 0 %  F B S+I n s  1  µg/ml, FBS + IBMX: DMEM + 10% FBS + IBMX 0.5mM, FBS +
dexamethasone [DEX]: DMEM + 10% FBS + Dex 0.25 mM, DM: DMEM + 10% FBS 
+I n s  1 µg/ml + IBMX 0.5 mM + Dex 0.25 mM; * P < 0.05, ** P < 0.01, *** P< 0.001).
Results
Change in eotaxin level during 3T3-L1 adipocyte differentiation
To investigate the changes in eotaxin expression during 3T3-L1 
adipocyte differentiation, we collected cells every other day after 
inducing differentiation in 3T3-L1 preadipocytes and measured 
expression levels of eotaxin mRNA and protein secretion. Eotaxin 
gene expression levels in preadipocytes were dramatically reduced 
after 2 days of treatment with differentiation-inducing media, but 
eotaxin levels increased gradually starting from day 4, in which 
differentiation-inducing media was removed and differentiation 
proceeded with insulin only (Fig. 1A). Compared to differentiation 
at day 2, eotaxin levels were 4-fold higher at day 6 and 5.8-fold 
higher at day 8. Similarly, secreted eotaxin protein levels in 
media were reduced during the initial phase of differentiation, 
but the level was 4.9-fold higher at day 6 of differentiation (Fig. 
1B). 
Changes in preadipocyte eotaxin levels due to a differentiation 
media component
To understand why eotaxin levels decreased dramatically following 
treatment with differentiation-inducing media in preadipocytes, 
we cultured preadipocytes under different media conditions (FBS: 
DMEM + 10% FBS; insulin: Ins; isobutylmethylxantine: IBM-X; 
dexamethasone: dex) for 24 hours, then assessed their eotaxin 
mRNA levels and changes in secreted serum eotaxin levels. As 
a result, eotaxin mRNA and protein levels both increased with 
insulin stimulation, but their levels decreased 8-11-fold following 
IBMX and dex stimulation (Fig. 2). 
Change in 3T3-L1 preadipocytes and adipocyte eotaxin levels 
following TNF-α stimulation
TNF-α, a strong inducer of inflammation, induces the synthesis 
of eotaxin in several cell types [19]. We stimulated preadipocytes 
and fully differentiated adipocytes with 10 ng/ml TNF-α and 
analyzed eotaxin mRNA levels and protein accumulation in the 
media at several time points after induction to elucidate the 
differences in eotaxin expression following TNF-α treatment. As 
shown in Fig. 3A and B, eotaxin mRNA levels and protein 
secretion levels in differentiated adipocytes increased up to 
40-fold following TNF-α stimulation. However, when preadipocytes 
were stimulated with TNF-α, eotaxin mRNA levels and protein 
secretion levels did not increase significantly (Fig. 3C, D). 14 Expression of eotaxin in adipocytes
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Fig. 3. Changes in eotaxin expression in 3T3-L1 preadipocytes and adipocytes after stimulation with TNF-α. (a) At day 8 after inducing differentiation, a time course 
treatment  with  10  ng/ml  TNF-α  was  conducted  for  30  minutes,  1  hour,  2  hours,  4  hours,  8  hours,  12 hours,  and 24 hours, the relative amount of eotaxin mRNA  was 
detected by real-time RT-PCR, and (b) eotaxin secretion were detected with an ELISA kit. (c) Time-course treatment with 10 ng/ml TNF-α on preadipocytes was conducted 
for 30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, and 24 hours, and (d) eotaxin secretion level was detected with an ELISA kit (*P<0.05, ** P<0.01, *** P <0.001).
Fig. 4. Changes in eotaxin expression in differentiated 3T3-L1 adipocytes 
following treatment with recombinant eotaxin.  At  8  days  after  inducing 
differentiation, adipocytes were treated with 10 ng/ml recombinant eotaxin, and the 
cells  were  collected  in  a  time  course.  The  relative  amount  of  eotaxin  mRNA 
expression  is  shown  (**P < 0.01).
Changes in 3T3-L1 adipocyte eotaxin levels following recombinant 
eotaxin treatment
When differentiated 3T3-L1 adipocytes were treated with 10 
ng/ml of recombinant eotaxin, eotaxin mRNA levels were highest 
at 2 h after treatment. The amount of eotaxin mRNA expression 
from adipocytes was 2.97-fold and 4.9-fold higher than that of 
the control, respectively (Fig. 4).
Changes in 3T3-L1 adipocyte eotaxin level following IL-4 and 
IL-5 stimulation
To indirectly investigate the effect of eosinophils infiltrating 
adipose tissue on adipocytes, differentiated 3T3-L1 adipocytes 
were treated with 10 ng/ml IL-4 or IL-5 secreted from eosinophils, 
and eotaxin mRNA levels and the amount of secreted eotaxin 
protein in media were measured at different time points. Eotaxin 
mRNA levels increased gradually due to IL-4; its levels were 
3.8-fold higher at 8 h compared to the control and continued 
increasing (Fig. 5A). After a 24-h treatment with IL-4, secreted 
eotaxin levels in media were 2.8-fold higher than that of the 
control (Fig. 5C). After IL-5 treatment, the eotaxin mRNA level 
was highest at 2 h and then decreased gradually. However, it 
increased again at 24 h (Fig. 5B). In contrast, secreted eotaxin 
levels in media after 24 h of IL-5 treatment were not significantly 
different than those of media without the treatment (Fig. 5D).
Changes in 3T3-L1 adipocyte eotaxin level following leptin 
stimulation
Exogenous leptin modulates the allergic airway response in 
mice [20], so we wondered about the effect of leptin on eotaxin 
expression in adipocytes. We treated differentiated adipocytes Hyun-Jung Kim et al. 15
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Fig. 5. Changes in eotaxin expression in 3T3-L1 adipocytes following interleukin (IL)-4 and IL-5 treatment. At day 8 after inducing differentiation, a time course treatment 
of  10  ng/ml  (a)  IL-4  and (b) IL-5  was conducted  for  30 minutes,  1  hour, 2 hours,  4  hours,  8  hours, 12  hours, and  24  hours,  and the relative amount of eotaxin mRNA 
was detected by real-time RT-PCR. (c) At day 8 after inducing differentiation, 10 ng/ml IL-4 and (d) IL-5 were added for 24 hours, and eotaxin secretion levels were detected 
with  an  ELISA  kit  (*P < 0.05,  ** P < 0.01,  *** P < 0.001).
(a) (b)
Fig. 6. Changes in eotaxin expression in 3T3-L1 adipocytes following leptin treatment. (a) At day 8 after inducing differentiation, a time course treatment of 100 pg/ml 
leptin  was  conducted  for  30  minutes,  1  hour,  2  hours,  4  hours,  8  hours,  12  hours,  and  24  hours,  and  the  relative  amount  of  eotaxin  mRNA  was  detected  by  real-time 
RT-PCR. (b) At day 8 after inducing differentiation, 100 pg/ml leptin was introduced for 4 hours, 8 hours, 12 hours, and 24 hours, and eotaxin secretion levels were detected
with  an  ELISA  kit  (*P < 0.05,  ** P < 0.01,  *** P < 0.001).
with 100 pg/ml of leptin and measured eotaxin mRNA levels 
and secreted eotaxin levels in media at different time periods. 
The results showed that the mRNA level at 4 h was 2.6-fold 
higher than the control and then decreased gradually. But, eotaxin 
increased again at 24 h to 1.6-fold higher than that of the control. 
The amount of secreted eotaxin during different time periods 
confirmed that levels increased gradually from 4 to 24 h (Fig. 
6A). However, the secreted eotaxin level was not significantly 
higher than that of mRNA (Fig. 6B).
Changes in mice adipose tissue eotaxin level following weight 
loss in high-fat diet (HFD) induced obese mice
Four-week-old C57BL/6 mice were fed a standard normal diet 
for 1 week to adapt. Then, the mice labeled “HFD” were switched 
to a HFD, which included 40% beef tallow (Table 1) and were 
maintained on this diet for 30 weeks, so the weight gain was 
sufficiently large. “HFDÆND” labeled mice were fed a HFD 
for 26 weeks and then switched to a normal diet for 4 weeks 16 Expression of eotaxin in adipocytes
Ingredients
Groups
Normal High fat diet
Casein 200.0 200.0
DL-Methionine 3.0 3.0
Cornstarch 150.0 150.0
Sucrose 500.0 150.0
Cellulose 50.0 50.0
Corn oil 50.0 -
Beef tallow - 400.0
Mineral mix 35.0 35.0
Vitamin mix 10.0 10.0
Choline bitarate 2.0 2.0
Fat energy (%) 5.0 40.0
Total (g) 1,000.0 1,000.0
Table 1. Nutritional composition of the normal and high-fat diets
Week 5 Week 6 Week 27 Week 30
ND 19.83 ± 0.65 19.83 ± 0.65 
(n = 43)
30.7 ± 2.22 
(n = 21)
30.31 ± 2.68 
(n = 16)
HFD 19.83 ± 0.65 19.83 ± 0.65 
(n = 43)
42.41 ± 7.15 
(n = 19)
44.11 ± 6.61***
(n = 8)
HFDÆND 19.83 ± 0.65 19.83 ± 0.65 
(n = 43)
42.41 ± 7.15 
(n = 19)
36.62 ± 5.90***
(n = 8)
*** Means  with  the  same  letters  are  significantly  different  (P < 0.001). 
Each  value  represents  mean ± SD.
ND, norm al diet; HFD, high-fat diet; HFDÆND, mice were fed a high-fat diet for 
26  weeks  then  switched  to  a  normal  diet
Table 2. Weight change in the mice groups (g)
(a) (b)
Fig. 7. Changes in adipose tissue eotaxin expression in different locations following diet-induced obesity and weight loss. The relative amount of eotaxin mRNA expression 
in  (a)  epididymal  adipose  tissues,  and  (b)  visceral  adipose  tissues  in  the  control  (CON),  HFD,  and  HFDÆND  were  observed  by  real-time  RT-PCR  (ND:  normal  diet;  HFD: 
high-fat  diet;  HFDÆND:  diet  induced  obesity  and  then  induced  weight  loss  by  normal d i e t ;  * P < 0.05,  ** P < 0.01,  *** P < 0.001).
(a)
(b)
Fig. 8. Changes in serum and bronchoalvelolar lavage fluid (BALF) eotaxin 
levels in the control (CON), high-fat diet fed (HFD), and high-fat diet switched 
to a normal diet after 26 weeks (HFDÆND) groups. (a) eotaxin levels in mice 
serum  and  (b)  in  BALF  were  detected  with  an  ELISA  kit  (* P < 0.05). to induce weight loss. The mice labeled “CON”, were standard 
mice, which maintained a normal diet for the entire period 
(controls). The HFD group had about a 31.2% greater weight 
gain compared to the CON group, and the HFDÆND group had 
about a 17% weight loss compared to the HFD group (Table 2). 
Comparing the change in eotaxin mRNA expression levels 
revealed that epididymal adipose tissue eotaxin levels and those 
of visceral adipose tissue were different. First, the HFD and HFD
ÆND groups both had reduced eotaxin mRNA levels in 
epididymal adipose tissue compared to the CON, and the HFD 
and HFDÆND groups were in a similar condition (Fig. 7A). 
In contrast, the HFD group had about 2.6-fold higher eotaxin 
mRNA levels in visceral adipose tissue than the CON group, 
and the HFDÆND group had about 5.4-fold lower compared 
to the HFD group (Fig. 7B).Hyun-Jung Kim et al. 17
Changes in serum and BALF eotaxin protein levels in HFD 
induced obese and weight loss mice
Eotaxin protein levels in mice serum were different from 
eotaxin mRNA levels in adipose tissue. In adipose tissues, the 
HFDÆND group had the lowest eotaxin mRNA levels in both 
visceral adipose tissue and epididymal adipose tissue, but the 
HFDÆND group had about 1.3-fold higher levels of eotaxin 
protein in serum than the CON group (Fig. 8A). 
Comparing both the HFD and HFDÆND groups with CON 
with regard to BALF eotaxin levels will bring us closer to 
understanding the relationship between obesity and asthma. The 
patterns of BALF eotaxin levels among the CON, HFD, and HFD
ÆND groups were similar to those of serum eotaxin (Fig. 8B). 
Discussion 
We were able to confirm that eotaxin expression increased with 
the progression of 3T3-L1 differentiation in adipocytes. Further-
more, we observed an increase in eotaxin expression in 3T3-L1 
adipocytes upon treatment with Th1/Th2 cytokines and chemokines 
such as TNF-α, eotaxin, IL-4, IL-5, and leptin. The level of 
eotaxin mRNA expression in visceral adipose tissues of HFD 
mice was much higher than the other groups, whereas the HFDÆ
ND group mice showed decreasing levels of mRNA expression. 
All mice showed insignificant differences in eotaxin levels in 
epididymal adipose tissue, serum, and BALF. 
The results of eotaxin expression studies on 3T3-L1 adipocytes 
to date have received several opinions. In past studies, eotaxin 
mRNA expression was higher in preadipocytes than in adipocytes 
and increased with LPS stimulation in both preadipocytes and 
adipocytes [17]. Therefore, we examined eotaxin mRNA expression 
and protein secretion levels at different stages of differentiation 
to determine eotaxin expression during 3T3-L1 adipocyte 
differentiation. Interestingly, our results showed that eotaxin 
expression levels decreased significantly at the early differentiation 
phase when IBMX and dex, which are differentiation induction 
components, were in the media. However, after removing the 
dex and IBMX, eotaxin levels increased gradually with differentiation 
in media with only insulin to induce differentiation. Dex is a 
synthetic glucocorticoid agonist that reduces inflammatory 
symptoms and immune reactions by stimulating the glucocorticoid 
receptor pathway. IBMX is a cAMP-phosphodiesterase inhibitor 
that reduces inflammatory symptoms and immune reactions by 
stimulating a cAMP-dependent protein kinase pathway, similar 
to dex [21]. Thus, reduced eotaxin levels in differentiation media 
were due to dex and IBMX. Consequently, this result explains 
the increased eotaxin levels after removing dex and IBMX. These 
data confirmed previous results stating that eotaxin mRNA levels 
are higher in preadipocytes than adipocytes [17], and suppressing 
eotaxin mRNA expression could be hypothesized as an effect 
of dex and IBMX anti-inflammatory activities during the 
induction of differentiation (Fig. 2). 
TNF-α is a primary inflammatory cytokine and a strong inducer 
of inflammation. Treating adipocytes with TNF-α is an indirect 
method to determine their response to conditions similar to low 
chronic systemic inflammation present in obese subjects and 
TNF-α secretion from infiltrating macrophages. We determined 
that eotaxin mRNA and secreted protein levels in both preadipocytes 
and adipocytes increased following TNF-α stimulation, but the 
amount of eotaxin mRNA and protein secretion levels in 
preadipocytes were lower than that in adipocytes, indicating that 
the chances of inflammation inducing cells, which retain eotaxin 
receptors such as eosinophils, infiltrating adipose tissue increase 
with increased eotaxin expression. 
Infiltrating cells, such as macrophages and eosinophils, occur 
in adipose tissue in addition to existing adipocytes. Obesity is 
thought to be responsible for the chemotaxis and infiltration of 
inflammation inducing cells, which mediate multiple metabolic 
diseases by inducing chronic low inflammation. Eotaxin is a 
chemokine expressed in both macrophages and eosinophils and, 
thus, treating adipocytes with eotaxin is an indirect method to 
determine the interaction between adipocytes in adipose tissue 
and stromal vascular cells. As expected, 3T3-L1 cells expressed 
more eotaxin mRNA following exogenous eotaxin stimulation. 
This indicated an increase in eotaxin mRNA expression in 
response to eotaxin stimulation, providing grounds for further 
studies with adipocyte and eosinophil co-cultures. This effect 
occurred much faster than with TNF-α treatment, and a continuous 
2 hrs of exposure did not affect expression. This result indicates 
the possibility of a signaling pathway independent of that of TNF-
α  and presents a need for further studies on the expression 
mechanism of eotaxin in adipocytes.
A variety of cell types are responsible for eotaxin production, 
and eotaxin is produced following IL-4 stimulation in normal 
human lung fibroblast cells, indicating that Th2 cytokines may 
regulate eotaxin production in lung fibroblasts [22]. So, we 
wondered about eotaxin synthesis in adipocytes following 
stimulation by Th2 cytokines such as IL-4 and IL-5, which are 
secreted by eosinophils [23,24]. When adipocytes were treated 
with IL-4, eotaxin mRNA expression increased significantly, and 
eotaxin secretion was also much higher, indicating the possibility 
of an increased inflammatory response in adipose tissues due 
to a synergetic effect between Th2 cytokines and adipocytes. 
Otherwise, adipocytes treated with IL-5 had increased eotaxin 
mRNA levels but not protein secretion levels. These results lead 
us to examine the different mechanisms of eotaxin synthesis in 
adipocytes following stimulation by Th2 cytokines, which can 
be helpful for understanding the link between obesity and asthma 
with eotaxin as a mediator.
Some of the proinflammatory effects of adipose tissue have 
been attributed to the hormone leptin, which is produced by 
adipose tissue [1]. Studies of exogenous leptin modulating 
allergic airway responses in mice indicate the possibility of a 
relationship between obesity and asthma through leptin [21]. 18 Expression of eotaxin in adipocytes
However, greater airway hyper-responsiveness and higher eotaxin 
levels were similarly observed after obese mice with a genetic 
deficiency in leptin were exposed to ozone [25]. These results 
show that leptin alone is insufficient to explain the relationship 
between obesity and asthma and led to a focus on the role of 
eotaxin. Therefore, we treated differentiated adipocytes with 
leptin. As a result, both eotaxin mRNA levels and the amount 
of secreted protein in adipocytes increased over time. Leptin, 
which increases with obesity, is a hormone that mediates obesity 
and inflammation. The result of increased eotaxin level in 
adipocytes due to leptin stimulation showed that the interaction 
between leptin and eotaxin has an effect on intensifying airway 
inflammation. This kind of interaction may play a significant 
role in the relationship between obesity and asthma. Therefore, 
more in-depth research on this mechanism is necessary.
Prior studies have shown increased eotaxin mRNA expression 
in adipose tissues of diet-induced obese mice when compared 
with that of normal mice. However, this study used obese mice 
that subsequently underwent weight loss through a normal diet. 
It has been reported that the visceral fat of obese human subjects 
shows significantly increased eotaxin mRNA expression compared 
with that of subcutaneous fat. Furthermore, unlike other CC 
chemokines, eotaxin has not shown any differences in expression 
in the subcutaneous fat of obese and normal human subjects [26].
We investigated eotaxin expression in visceral and epididymal 
adipose tissue and showed significant differences in expression 
in obese, weight-loss, and normal mice with regards to visceral 
fat, whereas little difference in expression was observed in 
epididymal fat. This result shows that adipose tissue may have 
differing functions depending on location. Further studies 
including determining CD68 and macrophage markers to assess 
infiltrating macrophages in tissue and determining eotaxin mRNA 
expression in each type of stromal vascular cells would allow 
for a deeper approach to understand the effects of infiltrating 
cells in adipose tissues.
Other studies have shown increased levels of eotaxin in serum 
and BALF of obese mice than normal mice; however, our results 
showed minimal differences in eotaxin levels in the three mice 
groups studied. Serum and BALF eotaxin levels are related to 
the onset and severity of asthma; thus, further research is required 
to attain accurate data. 
In conclusion, we have shown that eotaxin expression in 
3T3-L1 adipocytes increased during adipocyte differentiation 
and that an increase in eotaxin expression was observed 
following inflammatory stimulation with TNF-α, IL-4, IL-5, 
and leptin. Moreover, experiments on diet-induced obese mice 
show increased eotaxin mRNA expression in visceral adipose 
tissue due to a HFD and decreased levels upon weight loss. 
These results indicate a close relationship between eotaxin 
expression and obesity as well as weight loss and thus 
indirectly shows a relation to asthma. 
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